Literature DB >> 11737612

Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function.

S M Periyasamy1, J Chen, D Cooney, P Carter, E Omran, J Tian, S Priyadarshi, A Bagrov, O Fedorova, D Malhotra, Z Xie, J I Shapiro.   

Abstract

BACKGROUND: Diastolic dysfunction occurs in patients with chronic renal failure. Moreover, serum from uremic patients contains one or more inhibitors of the plasmalemmal Na,K-ATPase (sodium pump). We hypothesized that a circulating substance present in uremic sera contributes to both sodium pump inhibition and diastolic dysfunction.
METHODS: Serum samples were obtained from six patients with chronic renal failure and diastolic dysfunction.
RESULTS: Their serum samples caused marked inhibition of Na,K-ATPase purified from dog kidney at all concentrations studied (all P < 0.01) and also impaired ouabain-sensitive rubidium uptake by myocytes isolated from Sprague-Dawley rats (P < 0.01). These cardiac myocytes were studied for their contractile function with video-edge detection and calcium metabolism with indo-1 fluorescence spectroscopy after exposure to these uremic sera. These uremic sera caused increases in myocyte fractional shortening (P < 0.01) as well as an increase in the time constant of relengthening (P < 0.01). Examining the calcium transient, the time constant for calcium recovery was also increased (P < 0.01). Exposure of these cells to sera from age- and sex-matched healthy subjects did not result in significant changes in contraction or calcium cycling. Extracts of uremic serum samples inhibited isolated Na,K-ATPase whereas extracts of normal serum samples did not. The effect of uremic serum extracts on contractile function and calcium cycling were quite similar to that of intact serum or the addition of ouabain. Co-incubation of uremic serum extract with an antibody fragment directed against digoxin markedly attenuated the inhibition of Na,K-ATPase activity and completely prevented any effects on calcium cycling or contractile function.
CONCLUSION: These data show that one or more substances are present in uremic sera that acutely cause increased force of contraction and impaired recovery of cardiac myocyte calcium concentration as well as impaired relaxation. As these effects are similar to that seen with ouabain and can be prevented by co-incubation with an antibody fragment to digitalis, which also attenuates the sodium pump inhibitory effect, we suggest that this (these) substance(s) circulating in uremic sera and inhibiting the sodium pump also causes the acute diastolic dysfunction seen in our system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737612     DOI: 10.1046/j.1523-1755.2001.00053.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

Review 1.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 2.  Endogenous cardiotonic steroids and salt-sensitive hypertension.

Authors:  Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Biochim Biophys Acta       Date:  2010-03-27

Review 3.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

Review 4.  Cardiorenal Interactions: A Review.

Authors:  Sanam Verma; Michelle M Graham; Ashani Lecamwasam; Adam Romanovsky; Shelley Duggan; Sean Bagshaw; Janek Manoj Senaratne
Journal:  CJC Open       Date:  2022-07-16

5.  Low-dose growth hormone is cardioprotective in uremia.

Authors:  Ralph Rabkin; Ibrahim Awwad; Yu Chen; Euan A Ashley; Difei Sun; Sumita Sood; William Clusin; Paul Heidenreich; Grzegorz Piecha; Marie-Luise Gross
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

6.  Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong.

Authors:  Claudio Ronco; Andrew A House; Mikko Haapio
Journal:  Intensive Care Med       Date:  2008-02-05       Impact factor: 17.440

Review 7.  Na+/Ca2+ exchange and Na+/K+-ATPase in the heart.

Authors:  Michael J Shattock; Michela Ottolia; Donald M Bers; Mordecai P Blaustein; Andrii Boguslavskyi; Julie Bossuyt; John H B Bridge; Ye Chen-Izu; Colleen E Clancy; Andrew Edwards; Joshua Goldhaber; Jack Kaplan; Jerry B Lingrel; Davor Pavlovic; Kenneth Philipson; Karin R Sipido; Zi-Jian Xie
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

Review 8.  The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling?

Authors:  Joe X Xie; Anna Pearl Shapiro; Joseph Isaac Shapiro
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-17       Impact factor: 5.555

Review 9.  Cardiotonic Steroids and the Sodium Trade Balance: New Insights into Trade-Off Mechanisms Mediated by the Na⁺/K⁺-ATPase.

Authors:  Fatimah K Khalaf; Prabhatchandra Dube; Amal Mohamed; Jiang Tian; Deepak Malhotra; Steven T Haller; David J Kennedy
Journal:  Int J Mol Sci       Date:  2018-08-30       Impact factor: 5.923

Review 10.  Endogenous cardiotonic steroids and cardiovascular disease, where to next?

Authors:  Davor Pavlovic
Journal:  Cell Calcium       Date:  2019-12-27       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.